WPP
ARIA

Whalerock Point Partners’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Whalerock Point Partners’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-21,000
Closed -$122K – 160
2015
Q3 		$122K Hold
21,000
– – 0.05% 150
2015
Q2 		$173K Hold
21,000
– – 0.07% 145
2015
Q1 		$173K Hold
21,000
– – 0.07% 147
2014
Q4 		$144K Buy
21,000
+3,000
+17% +$18.8K 0.06% 141
2014
Q3 		$97K Buy
+18,000
New +$105K 0.04% 148

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Whalerock Point Partners's ARIA Position: Q4 2015 in Review

Whalerock Point Partners sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2015, closing a stake of 21,000 shares — an estimated $122K sold.

Whalerock Point Partners first reported a position in ARIA in Q3 2014 and held it in 5 quarters. The position peaked at $173K in Q2 2015. 172 funds tracked by Wall St. Rank hold ARIA as of Q4 2015.

  • Whalerock Point Partners reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Whalerock Point Partners sold 21,000 Ariad Pharmaceuticals Inc shares in Q4 2015, an estimated $122K.
  • Whalerock Point Partners first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and held it in 5 quarters.
  • Whalerock Point Partners's Ariad Pharmaceuticals Inc position peaked at $173K in Q2 2015.
  • 172 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2015.

Based on Whalerock Point Partners's 13F filing for Q4 2015, filed 10 Feb 2016.